MicroRNA‐382 Is Involved in Acute Kidney Injury via Regulating STAT1 Signaling
Journal of Immunology Research · 2026
DOI: 10.1155/jimr/5266272 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Immunology Research, 2026. Verfasst von Xiaoyan Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China, zs-hospital.sh.cn. Hauptthemen laut MEDLINE: STAT1 Transcription Factor, MicroRNAs, Acute Kidney Injury. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Commission of Shanghai Municipality, National Natural Science Foundation of China.
Abstract (Originalsprache)
Acute kidney injury (AKI), characterized by inflammation and oxidative stress, is a life‐threatening clinical presentation. We previously demonstrated the role of miR‐382 in the progression of chronic kidney disease (CKD). However, the role of miR‐382 in AKI is unknown. Genetic depletion of miR‐382 exacerbated renal dysfunction, histologic lesions, apoptosis of epithelial cells, and oxidative stress in kidneys in ischemia‐reperfusion (I/R)‐ and sepsis‐induced AKI. In vitro, downregulation of miR‐382 accompanied with activation of phosphorylation of signal transducer and activator of transcription 1 (STAT1) were induced in mouse renal tubular epithelial cells (mTECs) with hypoxia/reoxygenation (H/R) and lipopolysaccharide (LPS) treatments. Colocalization of phosphorylated STAT1 (p‐STAT1) and Lotus tetragonolobus lectin (LTL) suggested the activation of STAT1 signaling in renal epithelial after I/R injury (IRI). Overexpression of miR‐382 in mTECs abrogated phosphorylation of STAT1, generation of interleukin‐6 ( Il-6 ), tumor necrosis factor‐ α ( Tnf-α ), and Il-1β as well as reactive oxygen species (ROS) and apoptosis after H/R‐ and LPS treatments. Additionally, loss of miR‐382 was found in isolated macrophages from kidney during I/R‐induced AKI. Upregulation of miR‐382 in Raw264.7 cells inactivated STAT1 signaling and hindered polarization of M1 macrophages inhibiting Il-6 and inducible nitric oxide synthase ( iNos ). Inhibition of STAT1 pharmacologically reduced Il-1β , Il-6 , and Tnf-α in Raw264.7 after H/R. Taken together, these results demonstrated the protective role of miR‐382 in I/R‐ and sepsis‐induced AKI, suggesting miR‐382 as a novel therapeutic strategy for AKI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China, zs-hospital.sh.cn.
- International Medical Center, Zhongshan Hospital, Fudan University, Shanghai, China, zs-hospital.sh.cn.
- Clinical Research Unit, Institute of Clinical Science, Zhongshan Hospital, Fudan University, Shanghai, China, zs-hospital.sh.cn.
- Shanghai Medical Center of Kidney, Shanghai, China.
- Kidney and Dialysis Institute of Shanghai, Shanghai, China.
- Kidney and Blood Purification Laboratory of Shanghai, Shanghai, China.
ORCID-Profile: Xiaoyan Wang, Zhouping Zou, Ping Jia, Yi Fang, Xiaoqiang Ding
Förderung
- Science and Technology Commission of Shanghai Municipality
- National Natural Science Foundation of China
Zitieren
APA
Wang, X., Cheng, G., Ren, T., Zou, Z., Zhang, X., Zhao, S., Bao, S., Li, Y., Jia, P., Fang, Y., & Ding, X. (2026). MicroRNA‐382 Is Involved in Acute Kidney Injury via Regulating STAT1 Signaling. Journal of Immunology Research. https://doi.org/10.1155/jimr/5266272
Vancouver
Wang X, Cheng G, Ren T, Zou Z, Zhang X, Zhao S, et al. MicroRNA‐382 Is Involved in Acute Kidney Injury via Regulating STAT1 Signaling. Journal of Immunology Research. 2026. doi:10.1155/jimr/5266272
BibTeX
@article{Wang2026,
author = {Wang, Xiaoyan and Cheng, Guo and Ren, Ting and Zou, Zhouping and Zhang, Xinni and Zhao, Shuan and Bao, Siyu and Li, Yingxiang and Jia, Ping and Fang, Yi and Ding, Xiaoqiang},
title = {MicroRNA‐382 Is Involved in Acute Kidney Injury via Regulating STAT1 Signaling},
journal = {Journal of Immunology Research},
year = {2026},
doi = {10.1155/jimr/5266272}
}
EUVIMED